Krystexxa (pegloticase)

**Product type:** Human Prescription Drug

**Active ingredient:** PEGLOTICASE

**Strength:** 8 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Horizon Therapeutics USA, Inc.

**Marketing category:** BLA (BLA125293)

**Pharmacologic class:** Urate Oxidase [CS], Uric Acid-specific Enzyme [EPC]